Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for THER.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
December 31, 2023 -57.12M
September 30, 2023 -38.12M
June 30, 2023 -47.50M
March 31, 2023 -52.33M
December 31, 2022 -44.30M
September 30, 2022 -2.801M
June 30, 2022 -2.114M
March 31, 2022 -0.9187M
December 31, 2021 -1.866M
September 30, 2021 -1.945M
June 30, 2021 -1.433M
March 31, 2021 -1.168M
December 31, 2020 0.2329M
September 30, 2020 1.692M
June 30, 2020 1.044M
March 31, 2020
December 31, 2019 -15.94M
September 30, 2019 -13.68M
June 30, 2019 -12.87M
March 31, 2019 -11.49M
December 31, 2018 -7.547M
September 30, 2018 -10.24M
June 30, 2018 -9.803M
March 31, 2018 -5.172M
December 31, 2017
Date Value
September 30, 2017 -3.715M
June 30, 2017 2.087M
March 31, 2017 1.876M
December 31, 2016 -0.8266M
September 30, 2016 -0.3595M
June 30, 2016 -0.3362M
May 31, 2016
February 29, 2016
November 30, 2015
August 31, 2015
May 31, 2015 -0.0272M
February 28, 2015 -1.044M
November 30, 2014
August 31, 2014 -0.7129M
May 31, 2014 -0.7139M
February 28, 2014 -0.6208M
November 30, 2013 -0.2398M
August 31, 2013 -0.1481M
May 31, 2013 -0.0196M
February 28, 2013 0.0616M
November 30, 2012 0.6326M
August 31, 2012 0.9562M
May 31, 2012 0.0525M
February 29, 2012 0.2454M
November 30, 2011 0.1126M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Myriad Genetics, Inc. 303.90M
BioRestorative Therapies, Inc. 3.026M
Nanobac Pharmaceuticals, Inc. --
Biocept, Inc. --
CareDx, Inc. 425.60M